Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 28, 2023

BUY
$175.41 - $217.92 $35,959 - $44,673
205 Added 30.19%
884 $191,000
Q4 2022

Jan 26, 2023

SELL
$204.38 - $296.82 $160,233 - $232,706
-784 Reduced 53.59%
679 $0
Q3 2022

Oct 31, 2022

SELL
$195.21 - $310.53 $1.11 Million - $1.77 Million
-5,691 Reduced 79.55%
1,463 $407,000
Q2 2022

Jul 26, 2022

BUY
$115.91 - $214.48 $186,846 - $345,741
1,612 Added 29.09%
7,154 $1.37 Million
Q1 2022

Apr 27, 2022

BUY
$127.96 - $207.36 $403,201 - $653,391
3,151 Added 131.79%
5,542 $1.15 Million
Q4 2021

Jan 31, 2022

SELL
$165.13 - $241.83 $424,549 - $621,744
-2,571 Reduced 51.81%
2,391 $426,000
Q3 2021

Nov 03, 2021

SELL
$163.99 - $235.57 $29,026 - $41,695
-177 Reduced 3.44%
4,962 $1.02 Million
Q2 2021

Jul 30, 2021

BUY
$131.45 - $201.49 $675,521 - $1.04 Million
5,139 New
5,139 $975,000

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Dupont Capital Management Corp Portfolio

Follow Dupont Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Dupont Capital Management Corp with notifications on news.